bpc-157 fda warning news 2025 panel votes to place popular peptide on compounding list KOTA - An FDA advisory

While some patients might note transient mild fatigue or a brief period of mental haziness post-injection, its typically not of significant concern

This product is supplied strictly for laboratory and scientific research purposes only

It is thought to be beneficial for people suffering from Alzheimers disease and older adults with mental impairment

Thats because the GHK-Cu copper peptide has much more evidence in wound healing, improving skin laxity, reducing inflammation, and stimulating collagen and elastin productionits not typically recommended for appetite suppression or weight loss

A functional medicine approach helps you slow down, evaluate what is going on, and make decisions based on your real data and real life